Ontario has changed its cervical cancer screening to improve test accuracy and reduce frequency of screenings. In Canada, it ...
Zacks Investment Research on MSN8 小时
New Product Launches to Support HOLX Stock Amid Macro Issues
Hologic HOLX has been gaining from new strategic product launches across Diagnostics and Breast Health. However, ...
The collaboration between Quest and Google Cloud is the latest example of the use of AI agents in healthcare to automate complex tasks.
In a significant step towards enhancing healthcare access in rural Odisha, Vedanta Aluminium, in collaboration with BALCO Medical Centre (BMC), ...
Joya Griffin, DVM, DACVD, reminds Fetch Charlotte 2025 attendees to maintain a strong foundation when it comes to diagnosing ...
Aliko Scientific subsidiary Hospitex has won a public tender to supply cytology technology to the pathological anatomy department at the F Miulli Regional General Hospital in Italy. The five-year ...
Tethis collaborates with Sheba Medical Center to advance AI-powered liquid biopsy in rectal cancer: Milan, Italy Tuesday, March 11, 2025, 13:00 Hrs [IST] Tethis S.p.A., a pioneer ...
Hospitex, the Italian leader in the production of Cytology medical devices and fully owned subsidiary of ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), a company specializing in the ...
Fort Myers-headquartered NeoGenomics acquired New Jersey CLIA/CAP/NYS-certified laboratory Pathline LLC, expanding the ...
Investigators compared a urinary DNA methylation test with the nuclear matrix protein 22 (NMP22) and urine cytology tests.
Holger Neecke, CEO of Tethis. "Our See.d instrument, combined with our nanocoated SmartBioSurface slides, enables standardized preparation of cytology specimens containing immune and tumor cells, ...
Tethis S.p.A., a pioneer in standardized liquid biopsy platform development, and Sheba Medical Center, Israel's largest medical ...